Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Multicenter Study to Evaluate the Efficacy and Tolerability of a 4-week Therapy With the Combination of Valsartan 160mg + Amlodipine 5mg in Hypertensive Patients Not Adequately Responding to 4-week Treatment With Amlo 5mg or Felodipine 5mg in Monotherapy

NCT00392262 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00392262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00392262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Multicenter Study to Evaluate the Efficacy and Tolerability of a 4-week Therapy With the Combination of Valsartan 160mg + Amlodipine 5mg in Hypertensive Patients Not Adequately Responding to 4-week Treatment With Amlo 5mg or Felodipine 5mg in Monotherapy
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2006
Completion date
February 28, 2007
Enrollment
224 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension